연구성과로 돌아가기
2021 연구성과별 연구자 정보 (964 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Gas sensing behavior of p-NiO/n-ZnO composite nanofibers depending on varying p-NiO content: Selectivity and humidity-independence for oxidizing and reducing gas molecules | Choi, Myung Sik | Choi, MS | 2 | Kyungpook Natl Univ, Sch Nano & Mat Sci & Engn, Gyeongsangbuk Do 37224, South Korea | J-5687-2012 | Choi, Myung-Sik | khlee2018@yonsei.ac.kr;csw0427@kangwon.ac.kr; | |||
| Gas sensing behavior of p-NiO/n-ZnO composite nanofibers depending on varying p-NiO content: Selectivity and humidity-independence for oxidizing and reducing gas molecules | Lee, Kyu Hyoung | Lee, KH | 3 | 교신저자 | Yonsei Univ, Dept Mat Sci & Engn, Seoul 03722, South Korea | 0000-0001-6843-6706 | Lee, Kyu Hyoung | khlee2018@yonsei.ac.kr;csw0427@kangwon.ac.kr; | ||
| Gas sensing behavior of p-NiO/n-ZnO composite nanofibers depending on varying p-NiO content: Selectivity and humidity-independence for oxidizing and reducing gas molecules | Choi, Sun-Woo | Choi, SW | 4 | 교신저자 | Kangwon Natl Univ, Dept Mat Sci & Engn, Gangwon Do 25913, South Korea | khlee2018@yonsei.ac.kr;csw0427@kangwon.ac.kr; | ||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Pfeilstocker, M. | Pfeilstöcker, M | 1 | Hanusch Hosp, Vienna, Austria | AAN-6206-2021 | Pfeilstöcker, Michael | ||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Ravandi, F. | Ravandi, F | 2 | Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA | GOH-3538-2022 | Ravandi, Farhad | ||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Pocock, C. | Pocock, C | 3 | Kent & Canterbury Hosp, Canterbury, Kent, England | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Selleslag, D. | Selleslag, D | 4 | AZ Sint Jan Brugge Oostende AV, Brugge, Belgium | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Montesinos, P. | Montesinos, P | 5 | Hosp Univ Politecn La Fe, Valencia, Spain | GYU-2673-2022 | Montesinos, Pau | 0000-0002-3275-5593 | Montesinos, Pau | ||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Sayar, H. | Sayar, H | 6 | Indiana Univ, Canc Ctr, Indianapolis, IN 46204 USA | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Musso, M. | Musso, M | 7 | La Maddalena Casa Cura, Palermo, Italy | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Figuera, A. | Figuera, A | 8 | Hosp Univ La Princesa, Madrid, Spain | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Safah, H. | Safah, H | 9 | Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Tse, W. | Tse, W | 10 | Univ Louisville, Sch Med, Louisville, KY 40292 USA | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Sohn, S. K. | Sohn, SK | 11 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial | Hiwase, D. | Hiwase, D | 12 | Royal Adelaide Hosp, Adelaide, SA, Australia |
페이지 이동: